慢性呼吸道疾患の治療可能な特徴としての併発症
Mario Cazzola1, Nicola A Hanania2, Paola Rogliani1
1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Respiratory medicine
|August 31, 2025
まとめ
治療可能な特徴 (TT) モデルは,慢性呼吸道疾患における併発症を修正可能な特徴として再定義します. この精密医療アプローチは 疾患のラベルではなく 個々の特徴に焦点を当てて 患者の治療結果を改善します
科学分野:
- 肺科
- 精密医療
- 内科 医学
背景:
- 慢性呼吸道疾患 (喘息,COPD,気管切除症) は複雑で,併発性疾患の影響を受けています.
- 従来の病気のラベルは 患者の異質性を完全に捉えることはできません
- 肺の外的および行動的要因は,疾患管理に大きく影響する.
研究 の 目的:
- 慢性呼吸道疾患の治療可能な特徴 (TT) モデルを導入し,詳しく説明する.
- 病気を中心とした管理から 特徴を中心とした管理への移行を強調する
- 併発性疾患の役割を 特定・修正可能な特徴として強調する.
主な方法:
- 慢性呼吸道疾患と精密医療に関する最近の医学研究の文献レビュー.
- 特徴に基づく管理を評価する臨床試験と現実世界の研究の分析
- 治療可能な特徴モデルのための概念的枠組みの開発.
主要な成果:
- TTモデルは併発症を臨床的に関連し,特定し,修正可能な特徴として再定義します.
- 併発症を含む特質ベースの管理は,病気のコントロールと生活の質を改善します.
- 病気の制御が強化され,症状が軽減され,悪化が少なくなるという証拠があります.
結論:
- 治療可能な特徴モデルは 慢性呼吸道疾患に対して 患者中心の総合的なアプローチを提供します
- 多次元的な評価と多分野的なケアが TTモデルを実装する上で不可欠です.
- 将来の研究は,特性の識別と適応試験設計のためのAI/MLに焦点を当てるべきです.
関連する概念動画
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Other Pulmonary Disorders
905
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
905
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


